Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2014-06-30
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fe Absorption in Mother and Child Pairs From Wheat Fortified With Iron With and Without Phenolic Containing Beverages
NCT02437955
Improving Iron Status Through Consumption Of Iron Fortified Cowpea: An Intervention Study
NCT01208363
Iron Status in Infants in Ethiopia.
NCT03355287
Iron Bioavailability From Cereal-based Foods
NCT05061290
Defining the Serum Ferritin Concentration in Kenyan Women at Which the Body Senses Iron Depletion and Begins to Upregulate Iron Absorption
NCT05266703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NaFeEDTA
NaFeEDTA
NaFeEDTA
Ferrous fumarate
Ferrous fumarate
Ferrous fumarate
NaFeEDTA + ferrous fumarate
NaFeEDTA + ferrous fumarate
NaFeEDTA + ferrous fumarate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NaFeEDTA
Ferrous fumarate
NaFeEDTA + ferrous fumarate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Generally healthy
* Consenting to study participation
* Age 4 years +/- 12 months
* Generally healthy
Exclusion Criteria
* Weight \>65 kg
* Chronic illnesses which may influence iron absorption
* Severe anemia (Hb\<10 g/dl)
* Severe anemia (Hb\<10 g/dl)
* Weight for height \< -2 Z scores (wasting)
* Height of age \< -2 Z score (stunting)
* Chronic illnesses or medication which may influence iron absorption (will be judged by investigator)
* Consumption of vitamin or mineral supplement (unless they agree to discontinue using them two weeks before beginning of the study until the las visit)
* Allergies or intolerances relevant to the test meal (gluten)
* Blood donation or major blood losses during the 2 months prior to the study
* Illness during the 4 weeks prior to the study (will be judged by investigator)
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
International Atomic Energy Agency
OTHER_GOV
Swiss Federal Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Isabelle Aeberli
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle Aeberli, PhD
Role: PRINCIPAL_INVESTIGATOR
ETH Zurich (Switzerland)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ministère de la Santé Publique et de la Population
Port-au-Prince, , Haiti
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 2013-N43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.